Document and Entity Information
Document and Entity Information - USD ($) | 12 Months Ended | ||
Dec. 31, 2023 | Apr. 15, 2024 | Jun. 30, 2023 | |
Document and Entity Information | |||
Document Type | 10-K | ||
Document Annual Report | true | ||
Document Transition Report | false | ||
Document Period End Date | Dec. 31, 2023 | ||
Entity File Number | 001-41865 | ||
Entity Registrant Name | GLOBAL LIGHTS ACQUISITIONCORP | ||
Entity Incorporation, State or Country Code | E9 | ||
Entity Tax Identification Number | 00-0000000 | ||
Entity Address, Address Line One | Room 902, Unit 1, 8th Floor, Building 5 | ||
Entity Address, Address Line Two | No. 201, Tangli Road | ||
Entity Address, City or Town | Chaoyang District, Beijing | ||
Entity Address, Country | CN | ||
Entity Address, Postal Zip Code | 100123 | ||
City Area Code | +86 | ||
Local Phone Number | 10-5948-0786 | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Small Business | true | ||
Entity Emerging Growth Company | true | ||
Entity Ex Transition Period | false | ||
ICFR Auditor Attestation Flag | false | ||
Document Financial Statement Error Correction [Flag] | false | ||
Entity Shell Company | true | ||
Entity Public Float | $ 0 | ||
Entity Common Stock, Shares Outstanding | 8,975,000 | ||
Entity Central Index Key | 0001897971 | ||
Current Fiscal Year End Date | --12-31 | ||
Document Fiscal Year Focus | 2023 | ||
Document Fiscal Period Focus | FY | ||
Amendment Flag | false | ||
Auditor Name | Marcum Asia CPAs LLP | ||
Auditor Location | New York, NY | ||
Auditor Firm ID | 5395 | ||
Units, consisting of one Ordinary Share, $0.0001 par value, and one Right to acquire one-sixth of one Ordinary Share | |||
Document and Entity Information | |||
Title of 12(b) Security | Units, consisting of one Ordinary Share, $0.0001 par value, and one Right to acquire one-sixth of one Ordinary Share | ||
Trading Symbol | GLACU | ||
Security Exchange Name | NASDAQ | ||
Ordinary Shares, par value $0.0001 per share | |||
Document and Entity Information | |||
Title of 12(b) Security | Ordinary Shares, par value $0.0001 per share | ||
Trading Symbol | GLAC | ||
Security Exchange Name | NASDAQ | ||
Rights, each whole right to acquire one-sixth of one Ordinary Share | |||
Document and Entity Information | |||
Title of 12(b) Security | Rights, each whole right to acquire one-sixth of one Ordinary Share | ||
Trading Symbol | GLACR | ||
Security Exchange Name | NASDAQ |
BALANCE SHEETS
BALANCE SHEETS - USD ($) | Dec. 31, 2023 | Dec. 31, 2022 | ||
Current assets: | ||||
Cash | $ 1,391 | $ 315 | ||
Prepaid expenses | 308,564 | |||
Deferred offering costs | 836,340 | |||
Total Current Assets | 309,955 | 836,655 | ||
Investments held in trust account | 69,794,957 | |||
Total Assets | 70,104,912 | 836,655 | ||
Current liabilities: | ||||
Amount due to related parties | 110,665 | 808,287 | ||
Accrued expenses | 114,768 | 105,025 | ||
Total Current Liabilities | 225,433 | 913,312 | ||
Deferred underwriting fee payable | 2,415,000 | |||
Total Liabilities | $ 2,640,433 | $ 913,312 | ||
Other Liability, Current, Related Party, Type [Extensible Enumeration] | Related party | Related party | ||
Commitments and Contingencies | ||||
Ordinary shares subject to possible redemption, $0.0001 par value; 495,000,000 shares authorized; 6,900,000 shares at $10.12 redemption value and zero shares issued and outstanding as of December 31, 2023 and 2022, respectively | 69,794,957 | |||
Shareholder's Deficit | ||||
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding | ||||
Ordinary shares, $0.0001 par value, 495,000,000 shares authorized; 2,075,000 shares ( excluding 6,900,000 shares, subject to possible redemption) and 1,725,000 shares issued and outstanding as of December 31, 2023 and 2022, respectively(1) | [1],[2] | 208 | 173 | |
Share subscription receivable | (173) | (173) | ||
Accumulated deficit | (2,330,513) | (76,657) | ||
Total Shareholder's Deficit | (2,330,478) | (76,657) | [1],[2] | |
Total Liabilities, Temporary Equity, and Shareholders' Deficit | $ 70,104,912 | $ 836,655 | ||
[1] Includes an aggregate of up to 225,000 ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters as of December 31, 2022. As a result of the underwriter’s full exercise of their over-allotment option on November 16, 2023, no Founder Shares are currently subject to forfeiture as of December 31, 2023. On November 11, 2022, the Company issued 1,035,000 additional ordinary shares to the sponsor, which are identical to the previous issued 1,840,000 ordinary shares. On June 7, 2023, the Company repurchased and canceled 1,150,000 ordinary shares from the sponsor and off-set the consideration receivable from the sponsor. Total consideration receivable from the sponsor after off-set is $173 . All shares and associated amounts have been retroactively restated to reflect the issuance and cancellation of these shares (see Note 7). |
BALANCE SHEETS (Parenthetical)
BALANCE SHEETS (Parenthetical) - USD ($) | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Temporary equity, shares issued (in shares) | 6,900,000 | 0 |
Temporary equity, shares outstanding (in shares) | 6,900,000 | 0 |
Temporary equity redemption (in dollars per share) | $ 10.12 | $ 10.12 |
Preferred stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 |
Preferred stock, shares authorized (in shares) | 5,000,000 | 5,000,000 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Preferred stock, shares outstanding (in shares) | 0 | 0 |
Ordinary shares, par value (in dollars per share) | $ 0.0001 | $ 0.0001 |
Ordinary shares, shares authorized (in shares) | 495,000,000 | 495,000,000 |
Ordinary shares, shares issued (in shares) | 2,075,000 | 1,725,000 |
Ordinary shares, shares outstanding (in shares) | 2,075,000 | 1,725,000 |
Sponsor | ||
Additional shares issued | 1,035,000 | |
Number of new shares issued (in shares) | 1,840,000 | |
Number of shares repurchased and cancelled (in shares) | 1,150,000 | |
Value of shares issued net of shares repurchased and cancelled | $ 173 | |
Over allotment option | ||
Number of new shares issued (in shares) | 900,000 | |
Number of shares subject to forfeiture | 225,000 |
STATEMENTS OF OPERATIONS
STATEMENTS OF OPERATIONS - USD ($) | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | ||
Formation costs and operating costs | $ (369,963) | $ (73,277) | |
Loss from operations | (369,963) | (73,277) | |
Other income: | |||
Interest earned on investments held in Trust Account | 449,957 | ||
Net Income (Loss) | 79,994 | (73,277) | |
Ordinary shares subject to possible redemption | |||
Other income: | |||
Net Income (Loss) | $ 5,562,607 | ||
Basic, weighted average shares outstanding, ordinary shares (in shares) | 850,685 | ||
Diluted, weighted average shares outstanding, ordinary shares (in shares) | 850,685 | ||
Basic net income (loss) per ordinary share | $ 6.54 | ||
Diluted net income (loss) per ordinary share | $ 6.54 | ||
Non Redeemable Ordinary Shares | |||
Other income: | |||
Net Income (Loss) | $ (5,482,613) | $ (73,277) | |
Basic, weighted average shares outstanding, ordinary shares (in shares) | [1],[2] | 1,768,151 | 1,500,000 |
Diluted, weighted average shares outstanding, ordinary shares (in shares) | 1,768,151 | 1,500,000 | |
Basic net income (loss) per ordinary share | $ (3.10) | $ (0.05) | |
Diluted net income (loss) per ordinary share | $ (3.10) | $ (0.05) | |
[1] Includes an aggregate of up to 225,000 ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters as of December 31, 2022. As a result of the underwriter’s full exercise of their over-allotment option on November 16, 2023, no Founder Shares are currently subject to forfeiture as of December 31, 2023. On November 11, 2022, the Company issued 1,035,000 additional ordinary shares to the sponsor, which are identical to the previous issued 1,840,000 ordinary shares. On June 7, 2023, the Company repurchased and canceled 1,150,000 ordinary shares from the sponsor and off-set the consideration receivable from the sponsor. Total consideration receivable from the sponsor after off-set is $173 . All shares and associated amounts have been retroactively restated to reflect the issuance and cancellation of these shares (see Note 7). |
STATEMENTS OF OPERATIONS (Paren
STATEMENTS OF OPERATIONS (Parenthetical) - USD ($) | 12 Months Ended | ||
Nov. 16, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | |
Sponsor | |||
Additional shares issued | 1,035,000 | ||
Number of new shares issued (in shares) | 1,840,000 | ||
Number of shares repurchased and cancelled (in shares) | 1,150,000 | ||
Value of shares issued net of shares repurchased and cancelled | $ 173 | ||
Over allotment option | |||
Number of new shares issued (in shares) | 900,000 | 900,000 | |
Number of shares subject to forfeiture | 225,000 |
STATEMENTS OF CHANGES IN SHAREH
STATEMENTS OF CHANGES IN SHAREHOLDER'S DEFICIT - USD ($) | Ordinary Shares | Additional Paid in Capital | Share Subscription Receivable | Accumulated Deficit | Total | ||
Beginning balance at Dec. 31, 2021 | $ 173 | $ (173) | $ (3,380) | $ (3,380) | |||
Beginning balance (in shares) at Dec. 31, 2021 | 1,725,000 | ||||||
Net Income (loss) | (73,277) | (73,277) | |||||
Ending balance at Dec. 31, 2022 | [1],[2] | $ 173 | (173) | (76,657) | $ (76,657) | ||
Ending balance (in shares) at Dec. 31, 2022 | 1,725,000 | [1],[2] | 1,725,000 | ||||
Net Income (loss) | 79,994 | $ 79,994 | |||||
Issuance of Private Placement Units | $ 35 | $ 3,499,965 | 3,500,000 | ||||
Issuance of Private Placement Units (in shares) | 350,000 | ||||||
Issuance of Public Rights, net of issuance costs of $186,438 | 2,366,562 | 2,366,562 | |||||
Remeasurement for ordinary shares subject to Redemption Value | $ (5,866,527) | (2,333,850) | (8,200,377) | ||||
Ending balance at Dec. 31, 2023 | $ 208 | $ (173) | $ (2,330,513) | $ (2,330,478) | |||
Ending balance (in shares) at Dec. 31, 2023 | 2,075,000 | 2,075,000 | |||||
[1] Includes an aggregate of up to 225,000 ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters as of December 31, 2022. As a result of the underwriter’s full exercise of their over-allotment option on November 16, 2023, no Founder Shares are currently subject to forfeiture as of December 31, 2023. On November 11, 2022, the Company issued 1,035,000 additional ordinary shares to the sponsor, which are identical to the previous issued 1,840,000 ordinary shares. On June 7, 2023, the Company repurchased and canceled 1,150,000 ordinary shares from the sponsor and off-set the consideration receivable from the sponsor. Total consideration receivable from the sponsor after off-set is $173 . All shares and associated amounts have been retroactively restated to reflect the issuance and cancellation of these shares (see Note 7). |
STATEMENTS OF CHANGES IN SHAR_2
STATEMENTS OF CHANGES IN SHAREHOLDER'S DEFICIT (Parenthetical) | 12 Months Ended |
Dec. 31, 2023 USD ($) shares | |
Issuance cost net | $ | $ 186,438 |
Sponsor | |
Number of shares repurchased and cancelled (in shares) | shares | 1,150,000 |
Value of shares issued net of shares repurchased and cancelled | $ | $ 173 |
Over allotment option | |
Number of new shares issued (in shares) | shares | 900,000 |
STATEMENTS OF CASH FLOWS
STATEMENTS OF CASH FLOWS - USD ($) | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Cash Flows from Operating Activities: | ||
Net Income (loss) | $ 79,994 | $ (73,277) |
Adjustments to reconcile net loss to net cash (used in)/provided by operating activities: | ||
Interest earned on investments held in Trust Account | (449,957) | |
Changes in operating assets and liabilities: | ||
Prepaid expenses | (308,564) | |
Amount due to related parties | (697,622) | 73,592 |
Accrued expenses | (267,775) | |
Net cash (used in)/provided by operating activities | (1,643,924) | 315 |
Cash Flows from Investment Activities: | ||
Purchase of investments held in Trust Account | (69,345,000) | |
Net cash used in investing activities | (69,345,000) | |
Cash Flows from Financing Activities: | ||
Proceeds from sale of public units through public offering | 69,000,000 | |
Proceeds from sale of private placement units | 3,500,000 | |
Payment of underwriter's discount and commissions | (1,380,000) | |
Payments of deferred offering costs | (130,000) | |
Net cash provided by financing activities | 70,990,000 | |
Net change in cash | 1,076 | 315 |
Cash, beginning of the year | 315 | |
Cash, end of the year | 1,391 | 315 |
Supplemental disclosure of non-cash activities: | ||
Deferred underwriting discounts and commissions | 2,415,000 | |
Offering costs charged against additional paid-in capital | 1,243,858 | |
Remeasurement for ordinary shares subject to possible redemption | $ 8,200,377 | |
Deferred offering costs | 217,699 | |
Offering costs paid by related parties | 308,127 | |
Accrued expenses | $ (90,428) |
Description of Organization and
Description of Organization and Business Operations | 12 Months Ended |
Dec. 31, 2023 | |
Description of Organization and Business Operations | |
Description of Organization and Business Operations | Note 1 — Description of Organization and Business Operations Global Lights Acquisition Corp (the “Company”) is a blank check company incorporated in the Cayman Islands on August 23, 2021. The Company was incorporated for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities (a “Business Combination”). Although the Company is not limited to a particular industry or sector for purposes of consummating a Business Combination, the Company intends to focus its search on companies in and around several investment-worthy areas: (1) clean energy; (2) green financing; (3) circular economy; (4) energy technology; (5) low carbon consumption; and (6) carbon capture and storage, or CCS. As of December 31, 2023, the Company had not commenced any operations. All activities for the period from August 23, 2021 (inception) through December 31, 2023 are related to the Company’s formation, the initial public offering (“IPO”) and search for a target for its initial Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company has generated and expects to continue to generate non-operating income in the form of interest income from the proceeds derived from the IPO. The Company has selected December 31 as its fiscal year end. The Company’s sponsor is Carbon Neutral Holding Inc., a Cayman Islands exempted company (the “Sponsor”). The Company’s registration statement for the Company’s IPO was declared effective by the Securities and Exchange Commission (the “SEC”) on November 13, 2023 (the “Effective Date”). On November 16, 2023, the Company consummated the IPO of 6,900,000 units (the “Public Units”), including the full exercise of the over-allotment option of 900,000 Public Units granted to the underwriters. The Public Units were sold at an offering price of $10.00 per unit generating gross proceeds of $69,000,000. Simultaneously with the IPO, the Company sold to its Sponsor 350,000 units at $10.00 per unit (the “Private Units”) in a private placement generating total gross proceeds of $3,500,000. Each Public Unit consists of one ordinary share (the “Public Shares”), and one right to receive one one-sixth Transaction costs amounted to $5,038,858, consisted of $1,380,000 of underwriting fees, $2,415,000 of deferred underwriting fees (payable only upon completion of a Business Combination) and $1,243,858 of other offering costs. As of November 16, 2023, cash of $723,539 was held outside of the Trust Account (as defined below) and is available for the payment of offering costs and for working capital purposes. The Company has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of the Private Units subject to funding the Trust Account (as defined below), although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete a Business Combination having an aggregate fair market value of at least 80% of the assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on interest earned on the Trust Account) at the time of the agreement to enter into an initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act 1940, as amended (the “Investment Company Act”). Upon the closing of the IPO and the private placement on November 16, 2023, a total of $69,345,000 was placed in a trust account (“Trust Account”), located in the United States and invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account, as described below. Note 1 — Description of Organization and Business Operations – continued The Company will provide its holders of the outstanding Public Shares (the “public shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.05 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The Public Shares subject to redemption are recorded at a redemption value and classified as temporary equity upon the completion of the IPO in accordance with the Accounting Standards Codification (“ASC”) Topic 480 of the Financial Accounting Standard Board (FASB), “Distinguishing Liabilities from Equity.” The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 immediately prior to or upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association (the “Amended and Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transaction is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem Public Shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each public shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against or abstain from voting on the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the Company’s Sponsor and any of the Company’s officers or directors that may hold Founder Shares (the “Initial Shareholders”) have agreed (a) to vote their Founder Shares, Private Shares and any Public Shares purchased during or after the IPO in favor of approving a Business Combination and (b) to waive their right to exercise redemptions rights with respect to any of their shares (including the Founder Shares) in connection with a shareholder vote to approve, or sell the shares to the Company in any tender offer in connection with, a proposed Business Combination. If the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a partnership, limited partnership, syndicate (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company. The Initial Shareholders have agreed (a) to waive their redemption rights with respect to the Founder Shares, Private Shares and Public Shares held by them in connection with the completion of a Business Combination and (b) not to propose, or vote in favor of, an amendment to the Amended and Memorandum and Articles of Association that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination within the prescribed timeline, unless the Company provides the public shareholders with the opportunity to redeem their Public Shares in conjunction with any such vote. Note 1 — Description of Organization and Business Operations – continued The Company has until November 16, 2024 to consummate the initial Business Combination. In addition, if the Company is unable to consummate the initial Business Combination by November 16, 2024, the Sponsor (and/or its affiliates or designees) may, but is not obligated to, extend the period of time to consummate a business combination twice by an additional three months each time (up to by May 16, 2025 to complete a Business Combination) (the “Combination Period”), provided that, pursuant to the terms of the Amended and Memorandum and Articles of Association and the trust agreement entered into between the Company and Continental Stock Transfer & Trust Company on November 13, 2023, the only way to extend the time available for the Company to consummate the initial business combination is for the sponsor to deposit into the trust account $690,000 ($0.10 per share), on or prior to the date of the applicable deadline. The Amended and Restated Memorandum and Articles of Association requires that such an amendment be approved by the affirmative vote of a majority of the shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at a general meeting. The public shareholders will not be afforded an opportunity to vote on the Company’s extension of time to consummate an initial business combination beyond November 16, 2024, to February 16, 2025, up to May 16, 2025 described above or redeem their shares in connection with such extensions. If the Company is unbale to complete a Business Combination within the Combination period, it will trigger the automatic winding up, dissolution and liquidation pursuant to the terms of the Company’s Amended and Restated Memorandum and Articles of Association and the Company shall: (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares and Private Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than $10.05 per Public Share. Note 1 — Description of Organization and Business Operations – continued In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below $10.05 per Public Share, except as to any claims by a third party who executed a valid and enforceable agreement with the Company waiving any right, title, interest or claim of any kind they may have in or to any monies held in the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Going Concern Consideration As of December 31, 2023, the Company had cash of $1,391 and working capital of $ 84,522. Subsequent to the consummation of the IPO, the Company’s liquidity has been satisfied through the net proceeds from the IPO and the Private Placement. The Company has incurred and expects to continue to incur significant professional costs to remain as a publicly traded company and to incur significant transaction costs in pursuit of the consummation of a Business Combination. In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,000,000 of such Working Capital Loans may be converted into units of the post Business Combination entity at a price of $10.00 per unit (See Note 5). The Company initially has until November 16, 2024 to consummate the initial Business Combination. However, the Company may extend the period of time to consummate a Business Combination two times (up to by May 16, 2025 to complete a Business Combination). If the Company does not complete a Business Combination by November 16, 2024 (or up to by May 16, 2025, if extended), the Company will trigger an automatic winding up, dissolution and liquidation pursuant to the terms of the Amended and Restated Memorandum and Articles of Association. Accordingly, no vote would be required from the shareholders to commence such a voluntary winding up, dissolution and liquidation. If the Company is unable to consummate the Company’s initial Business Combination by November 16, 2024 (or up to by May 16, 2025, if extended), the Company will, as promptly as possible but not more than 10 business days thereafter, redeem 100% of the Company’s outstanding Public Shares for a pro rata portion of the funds held in the Trust Account, including a pro rata portion of any interest earned on the funds held in the Trust Account (lesser tax payables and liquidation expenses up to $100,000), and then seek to liquidate and dissolve. However, the Company may not be able to distribute such amounts as a result of claims of creditors which may take priority over the claims of the Company’s public shareholders. In the event of dissolution and liquidation, the Company’s Rights will expire and will be worthless. Note 1 — Description of Organization and Business Operations – continued In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that these conditions raise substantial doubt about the Company’s ability to continue as a going concern. In addition, if the Company is unable to complete a Business Combination within the Combination Period, the Company’s board of directors would proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company. There is no assurance that the Company’s plans to consummate a Business Combination will be successful within the Combination Period. As a result, management has determined that such additional condition also raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements does not include any adjustments that might result from the outcome of this uncertainty. Risk and Uncertainties As a result of the military action commenced in February 2022 by the Russian Federation and Belarus in the country of Ukraine and related economic sanctions, the Company’s ability to consummate a Business Combination, or the operations of a target business with which the Company ultimately consummates a Business Combination, may be materially and adversely affected. In October 2023, Hamas terrorists infiltrated Israel’s southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets. Hamas also launched extensive rocket attacks on the Israeli population and industrial centers located along Israel’s border with the Gaza Strip and in other areas within the State of Israel. These attacks resulted in thousands of deaths and injuries, and Hamas additionally kidnapped many Israeli civilians and soldiers. Following the attack, Israel’s security cabinet declared war against Hamas and commenced a military campaign against Hamas and other terrorist organizations in parallel to their continued rocket and terror attacks. The Company cannot currently predict the intensity or duration of Israel’s war against Hamas, nor can predict how this war will ultimately affect the Company’s ability to consummate a Business Combination. In addition, the Company’s ability to consummate a Business Combination may be dependent on the ability to raise equity and debt financing which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity in third-party financing being unavailable on terms acceptable to the Company or at all. The impact of these actions and related sanctions on the world economy and the specific impact on the Company’s financial position, results of operations and/or ability to consummate a Business Combination are not yet determinable. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2023 | |
Summary of Significant Accounting Policies | |
Summary of Significant Accounting Policies | Note 2 — Summary of Significant Accounting Policies Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes- Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had cash of $1,391 and $315 as of December 31, 2023 and 2022, respectively, and did not have any cash equivalents as of December 31, 2023 and 2022. Offering Costs Associated with Initial Public Offering The Company complies with the requirements of the Financial Accounting Standard Board (the “FASB”) Accounting Standards Codification (“ASC”) 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A – “Expenses of Offerings.” Offering costs were $5,038,858 consisting principally of underwriting, legal, accounting and other expenses that are directly related to the IPO and charged to shareholders’ deficit upon the completion of the IPO. Note 2 — Summary of Significant Accounting Policies – continued Ordinary Shares Subject to Possible Redemption The Company accounts for its ordinary share subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Ordinary share subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary share (including ordinary share that feature redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary share is classified as shareholders’ equity. The Company’s ordinary shares features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible redemption is presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. The Company’s redeemable ordinary share is subject to SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. The accretion or remeasurement is treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital). As of December 31, 2023, the amount of ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following table: As of December 31, 2023 Gross proceeds $ 69,000,000 Less Proceeds allocated to public rights (2,553,000) Allocation of offering costs related to redeemable shares (4,852,420) Plus Remeasurement of carrying amount to redemption value 8,200,377 Ordinary shares subject to possible redemption $ 69,794,957 Rights Except in cases where the Company is not the surviving company in a Business Combination, each holder of a right will automatically receive one-sixth one Note 2 — Summary of Significant Accounting Policies – continued The Company will not issue fractional shares in connection with an exchange of rights. Fractional shares will either be rounded down to the nearest whole share or otherwise addressed in accordance with the applicable provisions of the Cayman Islands law. As a result, the holders of the rights must hold rights in multiples of six in order to receive shares for all of the holders’ rights upon closing of a Business Combination. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of rights will not receive any of such funds with respect to their rights, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such rights, and the rights will expire worthless. Further, there are no contractual penalties for failure to deliver securities to the holders of the rights upon consummation of a Business Combination. Additionally, in no event will the Company be required to net cash settle the rights. Accordingly, the rights may expire worthless. The Company accounts for rights as either equity-classified or liability-classified instruments based on an assessment of the right’s specific terms and applicable authoritative guidance in FASB ASC 480, Distinguishing Liabilities from Equity and ASC 815, Derivatives and Hedging. The assessment considers whether the rights are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the rights meet all of the requirements for equity classification under ASC 815, including whether the rights are indexed to the Company’s own ordinary shares and whether the right holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of right issuance and as of each subsequent quarterly period end date while the rights are outstanding. For issued or modified rights that meet all of the criteria for equity classification, the rights are required to be recorded as a component of equity at the time of issuance. For issued or modified rights that do not meet all the criteria for equity classification, the rights are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the rights are recognized as a non-cash gain or loss on the statements of operations. As the rights issued upon the IPO and private placements meet the criteria for equity classification under ASC 480, therefore, the rights are classified as equity. Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. Note 2 — Summary of Significant Accounting Policies – continued ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2023 and 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. As of December 31, 2023 and 2022, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Fair Value of Financial Instruments ASC Topic 820 “Fair Value Measurements and Disclosures” defines fair value, the methods used to measure fair value and the expanded disclosures about fair value measurements. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between the buyer and the seller at the measurement date. In determining fair value, the valuation techniques consistent with the market approach, income approach and cost approach shall be used to measure fair value. ASC Topic 820 establishes a fair value hierarchy for inputs, which represent the assumptions used by the buyer and seller in pricing the asset or liability. These inputs are further defined as observable and unobservable inputs. Observable inputs are those that buyer and seller would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs reflect the Company’s assumptions about the inputs that the buyer and seller would use in pricing the asset or liability developed based on the best information available in the circumstances. The fair value hierarchy is categorized into three levels based on the inputs as follows: Level 1: Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment. Level 2: Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means. Level 3: Valuations based on inputs that are unobservable and significant to the overall fair value measurement. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. Note 2 — Summary of Significant Accounting Policies – continued Net Income (Loss) per Share The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The statements of operations include a presentation of income (loss) per redeemable share and income (loss) per non-redeemable share following the two-class method of income per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable ordinary shares and non-redeemable ordinary shares and the undistributed income (loss) is calculated using the total net income (loss) less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable ordinary shares. Any remeasurement of the accretion to redemption value of the ordinary shares subject to possible redemption was considered to be dividends paid to the public shareholders. For the years ended December 31, 2023 and 2022, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted income (loss)per share is the same as basic income (loss) per share for the period presented. The net income (loss) per share presented in the statement of operations is based on the following: For the year ended December 31, 2023 2022 Net Income (Loss) $ 79,994 $ (73,277) Remeasurement for ordinary shares subject to possible redemption (8,200,377) — Net loss including accretion of ordinary shares $ (8,120,383) $ (73,277) For the year ended December 31, 2023 2022 Non- Non- Redeemable Redeemable Redeemable Redeemable Ordinary Ordinary Ordinary Ordinary Shares Shares Shares Shares Basic and diluted net income (loss) per share: Numerators: Net loss $ (2,637,770) $ (5,482,613) $ — $ (73,277) Remeasurement for ordinary shares subject to possible redemption 8,200,377 — — — Allocation of net income (loss) $ 5,562,607 $ (5,482,613) $ — $ (73,277) Denominators: Weighted-average shares outstanding 850,685 1,768,151 — 1,500,000 Basic and diluted net income (loss) per share $ 6.54 $ (3.10) $ — $ (0.05) Recent Accounting Pronouncements In December 2023, the FASB issued ASU 2023-09, Improvement to Income Tax Disclosure. This standard requires more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. This standard also includes certain other amendments to improve the effectiveness of income tax disclosures. ASU 2023-09 is effective for public business entities, for annual periods beginning after December 15, 2024. For entities other than public business entities, the amendments are effective for annual periods beginning after December 15, 2025. The Company’s management does not believe the adoption of ASU 2023-09 will have a material impact on its financial statements and disclosures Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on our financial statements. |
Initial Public Offering
Initial Public Offering | 12 Months Ended |
Dec. 31, 2023 | |
Initial Public Offering | |
Initial Public Offering | Note 3 — Initial Public Offering On November 16, 2023, the Company consummated the IPO of 6,900,000 Public Units, including the full exercise of the over-allotment option of 900,000 Public Units granted to the underwriters. The Public Units were sold at an offering price of $10.00 per unit generating gross proceeds of $69,000,000. Each Public Unit consists of one Public Share, and one Public Rights to receive one-sixth |
Private Placement
Private Placement | 12 Months Ended |
Dec. 31, 2023 | |
Private Placement | |
Private Placement | Note 4 — Private Placement Simultaneously with the closing of the IPO, the Sponsor purchased an aggregate of 350,000 Private Units at a price of $10.00 per Private Unit for an aggregate purchase price of $3,500,000 in a private placement. Each Private Unit consists of one Private Share, and one Private Right to receive one-sixth |
Related Parties Transactions
Related Parties Transactions | 12 Months Ended |
Dec. 31, 2023 | |
Related Parties Transactions | |
Related Parties Transactions | Note 5 — Related Parties Transactions Founder Shares On November 11, 2022, December 2, 2021 and August 23, 2021, the Company issued an aggregate of 1,035,000, 840,000 and 1,000,000 ordinary shares respectively, to the Sponsor for an aggregate purchase price of $288. On June 7, 2023, the Company repurchased and canceled 1,150,000 ordinary shares from the Sponsor with a consideration of $115 and off-set the consideration receivable from the sponsor. Following which the Sponsor holds 1,725,000 ordinary shares (“Founder Shares”) in total and total consideration receivable from the sponsor after the off-set is $173. The Company did not receive payment for the Founder Shares as of December 31, 2023 and the $173 payment due to the Company is recorded as share subscription receivable. All the then existing shareholders and directors of the Company considered the stock issuance and stock repurchase and cancelation were part of the Company’s reorganization to result in 1,725,000 ordinary shares issued and outstanding prior to completion of the IPO. The Company believes it is appropriate to reflect the stock issuance and stock repurchase and cancelation on a retroactive basis pursuant to ASC 260. As a result, the Company had 1,725,000 and 1,725,000 founder shares issued and outstanding as of December 31, 2023 and 2022. The registration statement for the Company’s IPO became effective on November 13, 2023. As a result of the underwriter’s full exercise of their over-allotment option on November 16, 2023, no Founder Shares are currently subject to forfeiture. The Initial Shareholder has agreed, subject to certain limited exceptions, not to transfer, assign or sell any of its Founder Shares, (A) with respect to 50% of the Founder Shares, until the earlier of (i) six months after the date of the consummation of a Business Combination, or (ii) the date on which the closing price of the Company’s ordinary shares equals or exceeds $16.50 per share (as adjusted for share sub-division, share dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after the Business Combination, (B) with respect to the remaining 50% of the Founder Shares, until six months after the date of the consummation of the Business Combination, or (C) earlier, if, subsequent to the Business Combination, the Company consummates a subsequent liquidation, merger, share exchange or other similar transaction which results in all of the Company’s shareholders having the right to exchange their ordinary shares for cash, securities or other property. Promissory Note — Related Party On December 23, 2021, the Company’s Sponsor issued an unsecured promissory note (“Promissory Note”) to the Company, pursuant to which the Company may borrow up to an aggregate principal amount of $300,000. On October 24, 2023, the Company and the Sponsor made an amendment to the principal amount of the promissory note from $300,000 to $950,000. The Promissory Note is non-interest bearing and payable on the earlier of: (i) December 31, 2023 or (ii) the date on which the Company consummates an initial public offering of its securities. There was no outstanding balance of Promissory Note as of December 31, 2023 and 2022. Note 5 — Related Parties Transactions – continued Administrative Services Agreement The Company is obligated, commencing on November 14, 2023, to pay the Sponsor a monthly fee of $10,000 for office space, administrative and support services to such affiliate. Upon completion of a Business Combination or liquidation, the Company will cease paying these monthly fees. Accordingly, in the event the consummation of the Business Combination takes 12 months, the Sponsor will be paid a total of $120,000 ($10,000 per month) for office space, administrative and support services and will be entitled to be reimbursed for any out-of-pocket expenses. For the years ended December 31, 2023 and 2022, the Company has recognized $15,000 and $0, respectively, of administrative service fee, which is included in formation and operating costs on the statement of operations. Working Capital Loan In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor, or certain of the Company’s officers and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,000,000 of such Working Capital Loans may be converted into units of the post Business Combination entity at a price of $10.00 per unit, each unit consisting of one ordinary share and one right to receive one As of December 31, 2023 and 2022, the Company had no borrowings under the working capital loans. Extension Loan In order to extend the period of time to consummate a Business Combination twice by an additional three three one As of December 31, 2023 and 2022, the Company had no such extension loans. Amount Due to Related Parties For the Period from August 23, 2021 (inception) through December 31, 2023, the Company’s related party Moore (Dalian) Technology Co., Ltd (“Moore”), Beijing Huachuan Xingrun Investment Co., Ltd (“Huachuan”) and Miao Zhizhuang made several payments on behalf of the Company. The payments were non-interest bearing and had no due date. No. Names of related parties Relationship 1 Miao Zhizhuang The CEO and Charmain of the Company and the sole director of the Sponsor of the Company 2 Moore 80% equity interests owned by Miao Zhizhuang's spouse 3 Huachuan 40% equity interests owned by Miao Zhizhuang 4 Carbon Neutral Holdings Inc. Sponsor of the Company 5 Silk Road Industry Holdings Limited (1) 36% equity interests owned by Miao Zhizhuang Note 5 — Related Parties Transactions – continued Amount due to related parties consisted of the following as of December 31, 2023 and 2022: As of December 31, 2023 December 31, 2022 Carbon Neutral Holdings Inc. (2) $ 108,965 $ — Moore — 729,808 Miao Zhizhuang — 68,154 Huachuan 1,700 10,325 Amounts due to related parties $ 110,665 $ 808,287 (1) Silk Road Industry Holdings Limited, an affiliate of Miao Zhizhuang, entered into a compliance and anti-bribery consulting agreement with the Company in the amount of $55,203 on November 25, 2023. The consultation fee was $55,203 for the year ended December 31, 2023. (2) Carbon Neutral Holdings Inc., the Sponsor of the Company, repaid the amounts due to Moore, Miao Zhizhuang, and Huachuan on behalf of the Company of $793,926 , $211,482 and $10,325, respectively, on November 9, 2023. On November 16, 2023, $923,200 was repaid to Carbon Neutral Holdings Inc., upon the closing of the IPO out of proceeds from private placement. Also, Carbon Neutral Holdings Inc. deposited an additional $1,432 in the escrow account for Company operations on November 16, 2023. The administrative fees were $15,000 for the year ended December 31, 2023. |
Commitments
Commitments | 12 Months Ended |
Dec. 31, 2023 | |
Commitments | |
Commitments | Note 6 — Commitments Registration rights The holders of the Founder Shares, Private Units (and all underlying securities), and any shares that may be issued upon conversion of Working Capital Loans and the payment for the extension of the Combination Period have been entitled to registration rights pursuant to a registration rights agreement signed on November 13, 2023. The holders of these securities are entitled to make up to three demands, excluding short form registration demands, that the Company registers such securities of. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company has granted the underwriters a 45-day option to purchase up to 900,000 additional Public Units to cover over-allotments, at the IPO price, less the underwriting discounts and commissions. On November 16, 2023, the underwriters fully exercised the over-allotment option to purchase 900,000 Public Units, generating gross proceeds to the Company of $9,000,000. The underwriters were paid a cash underwriting discount of $0.20 per Public Unit 2.0% of the gross proceeds of the IPO, or $1,380,000. In addition, the underwriters are entitled to a deferred underwriting fee of 3.5% of the gross proceeds of the IPO, or $2,415,000, which will be paid upon the closing of a Business Combination from the amounts held in the Trust Account, subject to the terms of the underwriting agreement. Financial Advisory Agreement On November 20, 2023, the Company entered into a financial advisory agreement with Macforth Industries (N) Ltd. to assist the Company in identifying potential investors by December 31,2024. The Company has prepaid $200,000 in cash on November 22, 2023, and generated $30,770 in financial advisory fees in 2023. Macforth Industries (N) Ltd. are entitled to a financial advisory fees equal to 2.0% of the financing proceeds upon the closing of a Business Combination, which was contingent on the closing of the Business Combination. Right of First Refusal The Company shall give the underwriters the right (but not the obligation) of first refusal to act as the sole provider, from the closing of the Business Combination through the eighteen (18) month anniversary thereof, of any arrangement or facility enabling the Company to raise capital through the sale or other distribution of its shares or any other equity-linked securities directly or indirectly (e.g., by sales of immediately registered shares) to the public markets. |
Shareholders' Deficit
Shareholders' Deficit | 12 Months Ended |
Dec. 31, 2023 | |
Shareholders' Deficit | |
Shareholders' Deficit | Note 7 — Shareholders’ Deficit Preference shares — December 31, 2023 issued outstanding Ordinary shares — outstanding Rights — If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of rights will not receive any of such funds with respect to their rights, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such rights, and the rights will expire worthless. Further, there are no contractual penalties for failure to deliver securities to the holders of the rights upon consummation of a Business Combination. Additionally, in no event will the Company be required to net cash settle the rights. Accordingly, the rights may expire worthless. |
Recurring Fair Value Measuremen
Recurring Fair Value Measurements | 12 Months Ended |
Dec. 31, 2023 | |
Recurring Fair Value Measurements | |
Recurring Fair Value Measurements | Note 8 — Recurring Fair Value Measurements The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. As of December 31, 2023, the Company held Level 1 financial instruments, which are the Company’s marketable securities held in the Trust Account. The Company did not hold any Level 1 financial instruments as of December 31, 2022. The following table presents information about the Company’s assets and liabilities that were measured at fair value on a recurring basis as of December 31, 2023, and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. Significant Significant Quoted Prices Other Other Carrying Value in Active Observable Unobservable December 31, Markets Inputs Inputs 2023 (Level 1) (Level 2) (Level 3) Assets: Investments held in Trust Account - Money Market Fund $ 69,794,957 $ 69,794,957 $ — $ — $ 69,794,957 $ 69,794,957 $ — $ — |
Subsequent Events
Subsequent Events | 12 Months Ended |
Dec. 31, 2023 | |
Subsequent Events | |
Subsequent Events | Note 9 — Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date of this report that these financial statements were available to be issued. The Company did not identify any other subsequent events that would have required adjustment or disclosure in the financial statements. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2023 | |
Summary of Significant Accounting Policies | |
Basis of Presentation | Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. |
Emerging Growth Company | Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes- Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had cash of $1,391 and $315 as of December 31, 2023 and 2022, respectively, and did not have any cash equivalents as of December 31, 2023 and 2022. |
Offering Costs Associated with Initial Public Offering | Offering Costs Associated with Initial Public Offering The Company complies with the requirements of the Financial Accounting Standard Board (the “FASB”) Accounting Standards Codification (“ASC”) 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A – “Expenses of Offerings.” Offering costs were $5,038,858 consisting principally of underwriting, legal, accounting and other expenses that are directly related to the IPO and charged to shareholders’ deficit upon the completion of the IPO. |
Ordinary shares subject to possible redemption | Ordinary Shares Subject to Possible Redemption The Company accounts for its ordinary share subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Ordinary share subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary share (including ordinary share that feature redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary share is classified as shareholders’ equity. The Company’s ordinary shares features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible redemption is presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. The Company’s redeemable ordinary share is subject to SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. The accretion or remeasurement is treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital). As of December 31, 2023, the amount of ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following table: As of December 31, 2023 Gross proceeds $ 69,000,000 Less Proceeds allocated to public rights (2,553,000) Allocation of offering costs related to redeemable shares (4,852,420) Plus Remeasurement of carrying amount to redemption value 8,200,377 Ordinary shares subject to possible redemption $ 69,794,957 |
Rights | Rights Except in cases where the Company is not the surviving company in a Business Combination, each holder of a right will automatically receive one-sixth one The Company will not issue fractional shares in connection with an exchange of rights. Fractional shares will either be rounded down to the nearest whole share or otherwise addressed in accordance with the applicable provisions of the Cayman Islands law. As a result, the holders of the rights must hold rights in multiples of six in order to receive shares for all of the holders’ rights upon closing of a Business Combination. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of rights will not receive any of such funds with respect to their rights, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such rights, and the rights will expire worthless. Further, there are no contractual penalties for failure to deliver securities to the holders of the rights upon consummation of a Business Combination. Additionally, in no event will the Company be required to net cash settle the rights. Accordingly, the rights may expire worthless. The Company accounts for rights as either equity-classified or liability-classified instruments based on an assessment of the right’s specific terms and applicable authoritative guidance in FASB ASC 480, Distinguishing Liabilities from Equity and ASC 815, Derivatives and Hedging. The assessment considers whether the rights are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the rights meet all of the requirements for equity classification under ASC 815, including whether the rights are indexed to the Company’s own ordinary shares and whether the right holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of right issuance and as of each subsequent quarterly period end date while the rights are outstanding. For issued or modified rights that meet all of the criteria for equity classification, the rights are required to be recorded as a component of equity at the time of issuance. For issued or modified rights that do not meet all the criteria for equity classification, the rights are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the rights are recognized as a non-cash gain or loss on the statements of operations. As the rights issued upon the IPO and private placements meet the criteria for equity classification under ASC 480, therefore, the rights are classified as equity. |
Income Taxes | Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2023 and 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented. |
Concentration of Credit Risk | Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. As of December 31, 2023 and 2022, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments ASC Topic 820 “Fair Value Measurements and Disclosures” defines fair value, the methods used to measure fair value and the expanded disclosures about fair value measurements. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between the buyer and the seller at the measurement date. In determining fair value, the valuation techniques consistent with the market approach, income approach and cost approach shall be used to measure fair value. ASC Topic 820 establishes a fair value hierarchy for inputs, which represent the assumptions used by the buyer and seller in pricing the asset or liability. These inputs are further defined as observable and unobservable inputs. Observable inputs are those that buyer and seller would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs reflect the Company’s assumptions about the inputs that the buyer and seller would use in pricing the asset or liability developed based on the best information available in the circumstances. The fair value hierarchy is categorized into three levels based on the inputs as follows: Level 1: Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment. Level 2: Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means. Level 3: Valuations based on inputs that are unobservable and significant to the overall fair value measurement. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. |
Net Income (Loss) per Share | Net Income (Loss) per Share The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The statements of operations include a presentation of income (loss) per redeemable share and income (loss) per non-redeemable share following the two-class method of income per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable ordinary shares and non-redeemable ordinary shares and the undistributed income (loss) is calculated using the total net income (loss) less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable ordinary shares. Any remeasurement of the accretion to redemption value of the ordinary shares subject to possible redemption was considered to be dividends paid to the public shareholders. For the years ended December 31, 2023 and 2022, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted income (loss)per share is the same as basic income (loss) per share for the period presented. The net income (loss) per share presented in the statement of operations is based on the following: For the year ended December 31, 2023 2022 Net Income (Loss) $ 79,994 $ (73,277) Remeasurement for ordinary shares subject to possible redemption (8,200,377) — Net loss including accretion of ordinary shares $ (8,120,383) $ (73,277) For the year ended December 31, 2023 2022 Non- Non- Redeemable Redeemable Redeemable Redeemable Ordinary Ordinary Ordinary Ordinary Shares Shares Shares Shares Basic and diluted net income (loss) per share: Numerators: Net loss $ (2,637,770) $ (5,482,613) $ — $ (73,277) Remeasurement for ordinary shares subject to possible redemption 8,200,377 — — — Allocation of net income (loss) $ 5,562,607 $ (5,482,613) $ — $ (73,277) Denominators: Weighted-average shares outstanding 850,685 1,768,151 — 1,500,000 Basic and diluted net income (loss) per share $ 6.54 $ (3.10) $ — $ (0.05) |
Recent Accounting Pronouncements | Recent Accounting Pronouncements In December 2023, the FASB issued ASU 2023-09, Improvement to Income Tax Disclosure. This standard requires more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. This standard also includes certain other amendments to improve the effectiveness of income tax disclosures. ASU 2023-09 is effective for public business entities, for annual periods beginning after December 15, 2024. For entities other than public business entities, the amendments are effective for annual periods beginning after December 15, 2025. The Company’s management does not believe the adoption of ASU 2023-09 will have a material impact on its financial statements and disclosures Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on our financial statements. |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Summary of Significant Accounting Policies | |
Schedule of amount of ordinary shares subject to possible redemption reflected | As of December 31, 2023 Gross proceeds $ 69,000,000 Less Proceeds allocated to public rights (2,553,000) Allocation of offering costs related to redeemable shares (4,852,420) Plus Remeasurement of carrying amount to redemption value 8,200,377 Ordinary shares subject to possible redemption $ 69,794,957 |
Schedule of net income loss available to common stockholder | For the year ended December 31, 2023 2022 Net Income (Loss) $ 79,994 $ (73,277) Remeasurement for ordinary shares subject to possible redemption (8,200,377) — Net loss including accretion of ordinary shares $ (8,120,383) $ (73,277) |
Schedule of earnings per share, basic and diluted | For the year ended December 31, 2023 2022 Non- Non- Redeemable Redeemable Redeemable Redeemable Ordinary Ordinary Ordinary Ordinary Shares Shares Shares Shares Basic and diluted net income (loss) per share: Numerators: Net loss $ (2,637,770) $ (5,482,613) $ — $ (73,277) Remeasurement for ordinary shares subject to possible redemption 8,200,377 — — — Allocation of net income (loss) $ 5,562,607 $ (5,482,613) $ — $ (73,277) Denominators: Weighted-average shares outstanding 850,685 1,768,151 — 1,500,000 Basic and diluted net income (loss) per share $ 6.54 $ (3.10) $ — $ (0.05) |
Related Parties Transactions (T
Related Parties Transactions (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Related Parties Transactions | |
Schedule of amounts due to related parties | No. Names of related parties Relationship 1 Miao Zhizhuang The CEO and Charmain of the Company and the sole director of the Sponsor of the Company 2 Moore 80% equity interests owned by Miao Zhizhuang's spouse 3 Huachuan 40% equity interests owned by Miao Zhizhuang 4 Carbon Neutral Holdings Inc. Sponsor of the Company 5 Silk Road Industry Holdings Limited (1) 36% equity interests owned by Miao Zhizhuang As of December 31, 2023 December 31, 2022 Carbon Neutral Holdings Inc. (2) $ 108,965 $ — Moore — 729,808 Miao Zhizhuang — 68,154 Huachuan 1,700 10,325 Amounts due to related parties $ 110,665 $ 808,287 (1) Silk Road Industry Holdings Limited, an affiliate of Miao Zhizhuang, entered into a compliance and anti-bribery consulting agreement with the Company in the amount of $55,203 on November 25, 2023. The consultation fee was $55,203 for the year ended December 31, 2023. (2) Carbon Neutral Holdings Inc., the Sponsor of the Company, repaid the amounts due to Moore, Miao Zhizhuang, and Huachuan on behalf of the Company of $793,926 , $211,482 and $10,325, respectively, on November 9, 2023. On November 16, 2023, $923,200 was repaid to Carbon Neutral Holdings Inc., upon the closing of the IPO out of proceeds from private placement. Also, Carbon Neutral Holdings Inc. deposited an additional $1,432 in the escrow account for Company operations on November 16, 2023. The administrative fees were $15,000 for the year ended December 31, 2023. |
Recurring Fair Value Measurem_2
Recurring Fair Value Measurements (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Recurring Fair Value Measurements | |
Summary of assets and liabilities that were measured at fair value on a recurring basis | As of December 31, 2023, the Company held Level 1 financial instruments, which are the Company’s marketable securities held in the Trust Account. The Company did not hold any Level 1 financial instruments as of December 31, 2022. The following table presents information about the Company’s assets and liabilities that were measured at fair value on a recurring basis as of December 31, 2023, and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. Significant Significant Quoted Prices Other Other Carrying Value in Active Observable Unobservable December 31, Markets Inputs Inputs 2023 (Level 1) (Level 2) (Level 3) Assets: Investments held in Trust Account - Money Market Fund $ 69,794,957 $ 69,794,957 $ — $ — $ 69,794,957 $ 69,794,957 $ — $ — |
Description of Organization a_2
Description of Organization and Business Operations (Details) - USD ($) | 12 Months Ended | ||
Nov. 16, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | |
Description of Organization and Business Operations | |||
Total gross proceeds | $ 69,000,000 | ||
Number of shares issued per right (in shares) | 0.1667 | ||
Deferred underwriting fee payable | $ 2,415,000 | ||
Cash held in trust account | 1,391 | $ 315 | |
Minimum net tangible assets upon consummation of business combination | $ 5,000,001 | ||
Threshold percentage of public shares subject to redemption without company's prior written consent (in %) | 15% | ||
Obligation to redeem Public Shares if entity does not complete a Business Combination (in %) | 100% | ||
Period of extension for business combination each time | 3 months | ||
Threshold business days to provide notice in case of extension of Business Combination (in days) | 10 days | ||
Cash deposited into Trust account | $ 69,345,000 | ||
Threshold business days for redemption of public shares (in days) | 10 days | ||
Maximum net interest to pay dissolution expenses | $ 100,000 | ||
Number of days trust amount is distributed, in case of liquidation (in days) | 2 days | ||
Cash | $ 1,391 | $ 315 | |
Working capital | $ 84,522 | ||
Public units | |||
Description of Organization and Business Operations | |||
Number of shares in a unit (in shares) | 1 | ||
Number of rights in a unit (in shares) | 1 | ||
Number of shares issued per right (in shares) | 0.1667 | ||
Private placement units | |||
Description of Organization and Business Operations | |||
Number of shares in a unit (in shares) | 1 | ||
Number of rights in a unit (in shares) | 1 | ||
Number of shares issued per right (in shares) | 0.1667 | ||
Working Capital Loans | |||
Description of Organization and Business Operations | |||
Price of units (in $ per share) | $ 10 | ||
Loan conversion agreement warrant | $ 1,000,000 | ||
Sponsor | |||
Description of Organization and Business Operations | |||
Price of units (in $ per share) | $ 0.10 | ||
Cash deposited into Trust account | $ 690,000 | ||
Sponsor | Private placement units | |||
Description of Organization and Business Operations | |||
Number of units sold (in shares) | 350,000 | ||
Price of units (in $ per share) | $ 10 | ||
Total gross proceeds | $ 3,500,000 | ||
Maximum | Working Capital Loans | |||
Description of Organization and Business Operations | |||
Loan conversion agreement warrant | $ 1,000,000 | ||
Maximum | Sponsor | |||
Description of Organization and Business Operations | |||
Price of units (in $ per share) | $ 10.05 | ||
IPO | |||
Description of Organization and Business Operations | |||
Transaction costs | 5,038,858 | ||
Underwriting fees | 1,380,000 | $ 1,380,000 | |
Deferred underwriting fee payable | 2,415,000 | $ 2,415,000 | |
Other offering costs | 1,243,858 | ||
Cash held in trust account | $ 723,539 | ||
Threshold minimum aggregate fair market value as a percentage of the net assets held in the Trust Account (in %) | 80% | ||
Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination (in %) | 50% | ||
IPO | Public units | |||
Description of Organization and Business Operations | |||
Number of units sold (in shares) | 6,900,000 | ||
Price of units (in $ per share) | $ 10 | ||
Total gross proceeds | $ 69,000,000 | ||
Number of shares in a unit (in shares) | 1 | ||
Number of rights in a unit (in shares) | 1 | ||
Number of shares issued per right (in shares) | 0.1667 | ||
Share price (in $ per share) | $ 10.05 | ||
Over allotment option | |||
Description of Organization and Business Operations | |||
Price of units (in $ per share) | $ 0.20 | ||
Over allotment option | Public units | |||
Description of Organization and Business Operations | |||
Number of units sold (in shares) | 900,000 |
Summary of Significant Accoun_4
Summary of Significant Accounting Policies (Details) | 12 Months Ended | |
Dec. 31, 2023 USD ($) multiple shares | Dec. 31, 2022 USD ($) | |
Summary of Significant Accounting Policies | ||
Cash and cash equivalents | $ 1,391 | $ 315 |
Deferred offering costs | 836,340 | |
Number of shares issued per right (in shares) | shares | 0.1667 | |
Offering Cost | $ 5,038,858 | |
Unrecognized tax benefits | 0 | 0 |
Unrecognized tax benefits, penalties and accrued interest | 0 | 0 |
Provision for income tax | $ 0 | $ 0 |
Private Rights, multiples | multiple | 6 |
Summary of Significant Accoun_5
Summary of Significant Accounting Policies - ordinary shares subject to possible redemption (Details) | 12 Months Ended |
Dec. 31, 2023 USD ($) | |
Summary of Significant Accounting Policies | |
Gross proceeds | $ 69,000,000 |
Proceeds allocated to public rights | (2,553,000) |
Allocation of offering costs related to redeemable shares | (4,852,420) |
Remeasurement of carrying amount to redemption value | 8,200,377 |
Ordinary shares subject to possible redemption | $ 69,794,957 |
Summary of Significant Accoun_6
Summary of Significant Accounting Policies - Net Income (Loss) per Share (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Net loss including accretion of ordinary shares to redemption value | ||
Net Income (loss) | $ 79,994 | $ (73,277) |
Remeasurement for ordinary shares subject to possible redemption | (8,200,377) | |
Net loss including accretion of ordinary shares to redemption value | $ (8,120,383) | $ (73,277) |
Summary of Significant Accoun_7
Summary of Significant Accounting Policies - Basic and diluted net income (loss) per share (Details) - USD ($) | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | ||
Numerator | |||
Net loss | $ (8,120,383) | $ (73,277) | |
Remeasurement for ordinary shares subject to possible redemption | 8,200,377 | ||
Net Income (Loss) | 79,994 | (73,277) | |
Ordinary shares subject to possible redemption | |||
Numerator | |||
Net loss | (2,637,770) | ||
Remeasurement for ordinary shares subject to possible redemption | (8,200,377) | ||
Net Income (Loss) | $ 5,562,607 | ||
Denominator | |||
Basic, weighted average shares outstanding, ordinary shares (in shares) | 850,685 | ||
Diluted, weighted average shares outstanding, ordinary shares (in shares) | 850,685 | ||
Basic net income (loss) per ordinary share | $ 6.54 | ||
Diluted net income (loss) per ordinary share | $ 6.54 | ||
Non Redeemable Ordinary Shares | |||
Numerator | |||
Net loss | $ (5,482,613) | (73,277) | |
Net Income (Loss) | $ (5,482,613) | $ (73,277) | |
Denominator | |||
Basic, weighted average shares outstanding, ordinary shares (in shares) | [1],[2] | 1,768,151 | 1,500,000 |
Diluted, weighted average shares outstanding, ordinary shares (in shares) | 1,768,151 | 1,500,000 | |
Basic net income (loss) per ordinary share | $ (3.10) | $ (0.05) | |
Diluted net income (loss) per ordinary share | $ (3.10) | $ (0.05) | |
[1] Includes an aggregate of up to 225,000 ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters as of December 31, 2022. As a result of the underwriter’s full exercise of their over-allotment option on November 16, 2023, no Founder Shares are currently subject to forfeiture as of December 31, 2023. On November 11, 2022, the Company issued 1,035,000 additional ordinary shares to the sponsor, which are identical to the previous issued 1,840,000 ordinary shares. On June 7, 2023, the Company repurchased and canceled 1,150,000 ordinary shares from the sponsor and off-set the consideration receivable from the sponsor. Total consideration receivable from the sponsor after off-set is $173 . All shares and associated amounts have been retroactively restated to reflect the issuance and cancellation of these shares (see Note 7). |
Initial Public Offering (Detail
Initial Public Offering (Details) - USD ($) | 12 Months Ended | |
Nov. 16, 2023 | Dec. 31, 2023 | |
Description of Organization and Business Operations | ||
Total gross proceeds | $ 69,000,000 | |
Number of shares issued per right (in shares) | 0.1667 | |
Public units | ||
Description of Organization and Business Operations | ||
Number of shares in a unit (in shares) | 1 | |
Number of rights in a unit (in shares) | 1 | |
Number of shares issued per right (in shares) | 0.1667 | |
Private placement units | ||
Description of Organization and Business Operations | ||
Number of shares in a unit (in shares) | 1 | |
Number of rights in a unit (in shares) | 1 | |
Number of shares issued per right (in shares) | 0.1667 | |
IPO | Public units | ||
Description of Organization and Business Operations | ||
Number of units sold (in shares) | 6,900,000 | |
Price of units (in $ per share) | $ 10 | |
Total gross proceeds | $ 69,000,000 | |
Number of shares in a unit (in shares) | 1 | |
Number of rights in a unit (in shares) | 1 | |
Number of shares issued per right (in shares) | 0.1667 | |
Over allotment option | ||
Description of Organization and Business Operations | ||
Price of units (in $ per share) | $ 0.20 | |
Over allotment option | Public units | ||
Description of Organization and Business Operations | ||
Number of units sold (in shares) | 900,000 |
Private Placement (Details)
Private Placement (Details) | 12 Months Ended | |
Nov. 16, 2023 USD ($) multiple $ / shares shares | Dec. 31, 2023 USD ($) multiple $ / shares | |
Private Placement | ||
Total gross proceeds | $ | $ 69,000,000 | |
Private Rights, multiples | multiple | 6 | |
Private placement units | ||
Private Placement | ||
Private Rights, multiples | multiple | 6 | |
Number of rights issued per unit | 1 | |
Number of ordinary shares issued per right | 0.1667 | |
Number of ordinary shares issued per unit | 1 | |
Sponsor | ||
Private Placement | ||
Price of units (in $ per share) | $ / shares | $ 0.10 | |
Sponsor | Private placement units | ||
Private Placement | ||
Number of units sold (in shares) | 350,000 | |
Price of units (in $ per share) | $ / shares | $ 10 | |
Total gross proceeds | $ | $ 3,500,000 |
Related Parties Transactions -
Related Parties Transactions - Founder Shares (Details) | 12 Months Ended | |||||
Jun. 07, 2023 USD ($) shares | Nov. 11, 2022 shares | Dec. 02, 2021 shares | Aug. 23, 2021 shares | Dec. 31, 2023 USD ($) D $ / shares shares | Dec. 31, 2022 shares | |
Related Parties Transactions | ||||||
Aggregate purchase price | $ | $ 2,366,562 | |||||
Ordinary shares outstanding | 1,000,000 | 2,075,000 | 1,725,000 | |||
Ordinary shares issued | 840,000 | 1,000,000 | 2,075,000 | 1,725,000 | ||
Founder Shares | ||||||
Related Parties Transactions | ||||||
Shares held by Sponsor (in shares) | 1,725,000 | |||||
Ordinary shares outstanding | 1,725,000 | 1,725,000 | ||||
Ordinary shares issued | 1,725,000 | 1,725,000 | ||||
Sponsor | Founder Shares | ||||||
Related Parties Transactions | ||||||
Number of new shares issued (in shares) | 1,035,000 | 840,000 | 1,000,000 | |||
Aggregate purchase price | $ | $ 288 | |||||
Number of shares repurchased and cancelled (in shares) | 1,150,000 | |||||
Amount of shares repurchased and cancelled | $ | $ 115 | |||||
Shares held by Sponsor (in shares) | 1,725,000 | |||||
Value of shares held by Sponsor | $ | $ 173 | |||||
Sponsor | Founder Shares | Conditions for Initial Shareholders on 50% of Founder Shares | ||||||
Related Parties Transactions | ||||||
Restrictions on transfer period of time after business combination completion (in months) | 6 months | |||||
Stock price trigger to transfer, assign or sell any shares of the company, after the completion of the initial business combination (in dollars per share) | $ / shares | $ 16.50 | |||||
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination (in days) | D | 20 | |||||
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination (in days) | D | 30 | |||||
Sponsor | Founder Shares | Conditions for Initial Shareholders on remaining 50% of Founder Shares | ||||||
Related Parties Transactions | ||||||
Restrictions on transfer period of time after business combination completion (in months) | 6 months |
Related Parties Transactions (D
Related Parties Transactions (Details) - USD ($) | 12 Months Ended | ||||
Nov. 16, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | Oct. 24, 2023 | Dec. 23, 2021 | |
Related Parties Transactions | |||||
Administrative service fee | $ 15,000 | ||||
Cash Deposited Into Trust Account | $ 69,345,000 | ||||
Period of extension for business combination each time | 3 months | ||||
Operating Costs And Expenses | |||||
Related Parties Transactions | |||||
Administrative service fee | $ 15,000 | $ 0 | |||
Promissory Note with Related Party | |||||
Related Parties Transactions | |||||
Outstanding balance of related party note | 0 | 0 | $ 300,000 | ||
Promissory Note with Related Party | Minimum | |||||
Related Parties Transactions | |||||
Outstanding balance of related party note | $ 300,000 | ||||
Promissory Note with Related Party | Maximum | |||||
Related Parties Transactions | |||||
Outstanding balance of related party note | $ 950,000 | ||||
Administrative Services Agreement | |||||
Related Parties Transactions | |||||
Expenses per month | 10,000 | ||||
Expenses paid | 120,000 | ||||
Working Capital Loans | |||||
Related Parties Transactions | |||||
Loan conversion agreement into units | $ 1,000,000 | ||||
Price of units (in $ per share) | $ 10 | ||||
Number of ordinary shares issued per unit | 1 | ||||
Number of rights issued per unit | 1 | ||||
Number of ordinary shares issued per right | 0.1667 | ||||
Borrowings | $ 0 | 0 | |||
Working Capital Loans | Maximum | |||||
Related Parties Transactions | |||||
Loan conversion agreement into units | 1,000,000 | ||||
Extension Loan | |||||
Related Parties Transactions | |||||
Cash Deposited Into Trust Account | $ 690,000 | ||||
Cash Deposit into Trust Account, Share Price per Public Share | $ 0.10 | ||||
Period of extension for business combination each time | 3 months | ||||
Number of ordinary shares issued per unit | 1 | ||||
Number of rights issued per unit | 1 | ||||
Number of ordinary shares issued per right | 0.1667 | ||||
Extension loans | $ 0 | $ 0 | |||
Convertible units | $ 10 |
Related Parties Transactions _2
Related Parties Transactions - Schedule of amounts due to related parties (Details) - USD ($) | 12 Months Ended | ||||
Nov. 25, 2023 | Nov. 16, 2023 | Nov. 09, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | |
Related Parties Transactions | |||||
Amount due to related parties | $ 110,665 | $ 808,287 | |||
Administrative service fee | 15,000 | ||||
Related party | |||||
Related Parties Transactions | |||||
Amount due to related parties | 808,287 | ||||
Carbon Neutral Holdings Inc. | |||||
Related Parties Transactions | |||||
Amount due to related parties | $ 108,965 | ||||
Repayments of amount due to related parties | $ 923,200 | ||||
Escrow deposit | $ 1,432 | ||||
Moore | |||||
Related Parties Transactions | |||||
Equity interest ownership percentage | 80% | ||||
Amount due to related parties | 729,808 | ||||
Repayments of amount due to related parties | $ 793,926 | ||||
Miao Zhizhuang | |||||
Related Parties Transactions | |||||
Amount due to related parties | 68,154 | ||||
Repayments of amount due to related parties | 211,482 | ||||
Consulting service from the Company | $ 55,203 | $ 55,203 | |||
Huachuan | |||||
Related Parties Transactions | |||||
Equity interest ownership percentage | 40% | ||||
Amount due to related parties | $ 1,700 | $ 10,325 | |||
Repayments of amount due to related parties | $ 10,325 | ||||
Silk Road Industry Holding Limited | |||||
Related Parties Transactions | |||||
Equity interest ownership percentage | 36% |
Commitments - Additional Inform
Commitments - Additional Information (Details) | 12 Months Ended | |||
Nov. 22, 2023 USD ($) | Nov. 20, 2023 USD ($) | Nov. 16, 2023 USD ($) shares | Dec. 31, 2023 USD ($) item $ / shares shares | |
Subsidiary, Sale of Stock [Line Items] | ||||
Maximum number of demands for registration of securities | item | 3 | |||
Number of days on options to underwriting | 18 months | |||
Aggregate purchase price | $ 2,366,562 | |||
Deferred underwriting fee payable | $ 2,415,000 | |||
Prepaid in cash | $ 200,000 | |||
Financial advisory fees | $ 30,770 | |||
Financial advisory fees, percentage of financing proceeds | 2% | |||
Over allotment option | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Number of days on options to underwriting | 45 days | |||
Number of new shares issued (in shares) | shares | 900,000 | 900,000 | ||
Price of units (in $ per share) | $ / shares | $ 0.20 | |||
Aggregate purchase price | $ 9,000,000 | |||
IPO | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Percentage of gross proceeds | 2% | |||
Underwriting fees | 1,380,000 | $ 1,380,000 | ||
Deferred underwriting fee (in Percent) | 3.50% | |||
Deferred underwriting fee payable | $ 2,415,000 | $ 2,415,000 |
Shareholders' Deficit - Prefere
Shareholders' Deficit - Preference shares (Details) - $ / shares | Dec. 31, 2023 | Dec. 31, 2022 |
Shareholders' Deficit | ||
Preferred stock, shares authorized (in shares) | 5,000,000 | 5,000,000 |
Preferred stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Preferred stock, shares outstanding (in shares) | 0 | 0 |
Shareholders' Deficit - Additio
Shareholders' Deficit - Additional Information (Details) - USD ($) | 12 Months Ended | ||||||
Jun. 07, 2023 | Dec. 31, 2023 | Nov. 16, 2023 | Dec. 31, 2022 | Nov. 11, 2022 | Dec. 02, 2021 | Aug. 23, 2021 | |
Class of Stock [Line Items] | |||||||
Ordinary shares, shares authorized (in shares) | 495,000,000 | 495,000,000 | |||||
Ordinary shares, par value (in dollars per share) | $ 0.0001 | $ 0.0001 | |||||
Number of vote per share | one | ||||||
Ordinary shares issued | 2,075,000 | 1,725,000 | 840,000 | 1,000,000 | |||
Ordinary shares outstanding | 2,075,000 | 1,725,000 | 1,000,000 | ||||
Temporary equity, shares issued (in shares) | 6,900,000 | 0 | |||||
Shares issued | 1,840,000 | ||||||
Sponsor | |||||||
Class of Stock [Line Items] | |||||||
Ordinary shares issued | 1,035,000 | 1,000,000 | |||||
Repurchase of common stock | 1,150,000 | ||||||
Total consideration receivable | $ 173 | ||||||
Shares issued | 350,000 |
Recurring Fair Value Measurem_3
Recurring Fair Value Measurements (Details) - Recurring | Dec. 31, 2023 USD ($) |
Carrying Value | |
Assets: | |
Investments held in Trust Account - Money Market Fund | $ 69,794,957 |
Assets | 69,794,957 |
Fair Value | Quoted Prices in Active Markets (Level 1) | |
Assets: | |
Investments held in Trust Account - Money Market Fund | 69,794,957 |
Assets | $ 69,794,957 |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Pay vs Performance Disclosure | ||
Net Income (Loss) | $ 79,994 | $ (73,277) |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended |
Dec. 31, 2023 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |